Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

CVS raises annual COVID-related revenue forecast to $3 billion

Stock Markets Aug 03, 2022 03:22PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: CVS Health logo is seen displayed in this illustration taken, May 3, 2022. REUTERS/Dado Ruvic/Illustration

By Bhanvi Satija and Leroy Leo

(Reuters) - CVS Health Corp (NYSE:CVS) on Wednesday lifted its annual outlook for COVID-19-related revenue as it expects sales of over-the-counter coronavirus tests to more than double this year, sending shares up over 5%.

The largest U.S. pharmacy chain also raised its forecast for annual COVID vaccinations by 2 million to 20 million, reflecting the demand for more boosters.

Pharmacy chain operators such as CVS have benefited from distributing COVID vaccines and tests, but demand for lab tests and vaccinations has slowed in recent months as overall coronavirus cases in the United States remain steady.

CVS administered about 6 million COVID shots nationwide in the second quarter, Chief Executive Officer Karen Lynch said, sharply lower from over 20 million in the last quarter of 2021.

The company forecast annual COVID-related revenue of $3 billion, as it now expects sales to drop by about a third compared with its earlier forecast of a two-thirds slump.

CVS also raised its adjusted profit outlook to $8.40-$8.60 per share from $8.20-$8.40 per share after its second-quarter earnings beat Wall Street estimates.

The outlook, especially for its insurance business, is conservative for the second half the year due to COVID-related uncertainty, Evercore analysts Elizabeth Anderson and Michael Newshel said in a note.

Excluding one-off items, the company reported quarterly earnings per share of $2.40 compared with analysts' average estimate of $2.17, as per Refinitiv IBES data.

(By Leroy Leo and Bhanvi Satija in Bengaluru and Caroline Humer in New York; Editing by Vinay Dwivedi)

CVS raises annual COVID-related revenue forecast to $3 billion
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email